Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Accumulated Expenses (2020 - 2025)

BioAtla (BCAB) has 4 years of Other Accumulated Expenses data on record, last reported at $1.0 million in Q4 2024.

  • For Q4 2024, Other Accumulated Expenses rose 20.58% year-over-year to $1.0 million; the TTM value through Dec 2024 reached $1.0 million, up 20.58%, while the annual FY2024 figure was $1.0 million, 20.58% up from the prior year.
  • Other Accumulated Expenses reached $1.0 million in Q4 2024 per BCAB's latest filing, up from $786000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.8 million in Q2 2022 and bottomed at $542000.0 in Q3 2023.
  • Average Other Accumulated Expenses over 4 years is $934384.6, with a median of $879000.0 recorded in 2023.
  • Peak YoY movement for Other Accumulated Expenses: soared 181.49% in 2022, then crashed 50.59% in 2023.
  • A 4-year view of Other Accumulated Expenses shows it stood at $1.1 million in 2021, then rose by 19.2% to $1.3 million in 2022, then crashed by 32.37% to $865000.0 in 2023, then rose by 20.58% to $1.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1.0 million in Q4 2024, $786000.0 in Q3 2024, and $865000.0 in Q4 2023.